15 studies found for:    glioblastoma | Open Studies | Interventional Studies | Phase 3
Show Display Options
Rank Status Study
1 Recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Conditions: Glioblastoma;   Small Cell Glioblastoma;   Giant Cell Glioblastoma;   Gliosarcoma;   Glioblastoma With Oligodendroglial Component
Interventions: Drug: Rindopepimut (CDX-110) with GM-CSF;   Drug: Temozolomide;   Drug: KLH
2 Recruiting Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Radiotherapy;   Radiation: Experimental arm
3 Recruiting Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma
Condition: Newly-diagnosed Glioblastoma
Interventions: Drug: Losartan;   Drug: Placebo
4 Not yet recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma
Interventions: Drug: temozolomide;   Drug: veliparib;   Other: placebo;   Other: laboratory biomarker analysis
5 Recruiting Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
Condition: Glioblastoma
Interventions: Drug: Temozolomide and lomustine;   Drug: Temozolomide
6 Recruiting Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Conditions: Glioblastoma Multiforme;   Glioblastoma;   GBM;   Grade IV Astrocytoma;   Glioma;   Brain Cancer;   Brain Tumor
Intervention: Drug: Dendritic cell immunotherapy
7 Recruiting A Comparison of Continuous Avastin (Bevacizumab) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Patients With Glioblastoma
Condition: Glioblastoma
Interventions: Drug: bevacizumab [Avastin];   Drug: temozolomide;   Radiation: Radiotherapy;   Drug: placebo;   Drug: SOC;   Drug: lomustine
8 Recruiting MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
Condition: Glioblastoma
Interventions: Drug: 5-aminolévulinique acid (5-ALA);   Drug: Placebo
9 Recruiting Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Device: NovoTTF-100A device;   Drug: Temozolomide
10 Recruiting Bevacizumab and Lomustine for Recurrent GBM
Conditions: Brain and Central Nervous System Tumors;   Cognitive/Functional Effects
Interventions: Biological: bevacizumab;   Drug: lomustine;   Genetic: DNA methylation analysis;   Other: laboratory biomarker analysis;   Procedure: cognitive assessment;   Procedure: quality-of-life assessment
11 Recruiting Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Fatigue
Interventions: Drug: armodafinil 150 mg;   Other: Placebo;   Drug: armodafinil 250 mg
12 Not yet recruiting Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
Conditions: Childhood Central Nervous System Choriocarcinoma;   Childhood Central Nervous System Germinoma;   Childhood Central Nervous System Mixed Germ Cell Tumor;   Childhood Central Nervous System Teratoma;   Childhood Central Nervous System Yolk Sac Tumor;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Extracranial Germ Cell Tumor;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Malignant Ovarian Germ Cell Tumor;   Childhood Malignant Testicular Germ Cell Tumor;   Childhood Medulloepithelioma;   Childhood Supratentorial Ependymoma;   Childhood Teratoma;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Central Nervous System Embryonal Tumor;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Malignant Germ Cell Tumor;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma;   Recurrent Retinoblastoma;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: etoposide;   Drug: ifosfamide;   Drug: carboplatin;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: cyclophosphamide;   Drug: cisplatin;   Biological: filgrastim;   Other: laboratory biomarker analysis
13 Not yet recruiting Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma
Interventions: Drug: Carmustine;   Procedure: tumor resection surgery
14 Recruiting A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: Temozolomide;   Drug: α-IFN
15 Recruiting C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
Condition: Gliomas
Intervention: Drug: Sodium Acetate C11 PET/CT Imaging

Indicates status has not been verified in more than two years